SCHEMBL473606

SCHEMBL473606

C=COc1ccc(OC=C)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 2/20 0.34
CHRNA4 P43681 2/20 0.34
ALDH1A1 P00352 3/20 0.33
TP53 P04637 2/20 0.33
TSHR P16473 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CYP3A4 P08684 1/20 0.33
ALOX15 P16050 1/20 0.33
ALOX12 P18054 1/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
XBP1 P17861 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
MDM2 Q00987 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11965976 0.91 ESR2 (0.33) CHRNB2CHRNA4ALDH1A1TP53TSHR
SCHEMBL14289128 0.91 ALDH1A1 (0.44) ALDH1A1TP53TSHRSMN1; SMN2CYP3A4
SCHEMBL126186 0.86 ALDH1A1 (0.58) CHRNB2CHRNA4ALDH1A1TP53TSHR
SCHEMBL3391634 0.86 APP (0.39) CHRNB2CHRNA4CYP3A4CA1CA2
SCHEMBL194685 0.86 LMNA (0.42) ALDH1A1SMN1; SMN2CYP3A4LMNAMAPT
SCHEMBL24636596 0.86 CHRNB2 (0.30) CHRNB2CHRNA4
SCHEMBL274124 0.86 CA1 (0.58) ALDH1A1TP53TSHRSMN1; SMN2CYP3A4
SCHEMBL14605389 0.86 IDO1 (0.33) CHRNB2CHRNA4
SCHEMBL410307 0.86 NFE2L2 (0.41) ALDH1A1LMNACA1CA2CA7
SCHEMBL194091 0.86 ACHE (0.48) ALDH1A1TSHRSMN1; SMN2CYP3A4NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 539 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025075380-A1 ADDITIVE COMPOSITION FOR MODIFIED ASPHALT AND MODIFIED ASPHALT COMPOSITION COMPRISING SAME 금호석유화학 주식회사 2025-04-10 WO claimed
CN-112143284-B Radiation-curable ink and use thereof 常州强力电子新材料股份有限公司 2022-09-27 CN claimed
CN-112143284-A Radiation-curable ink and use thereof 常州强力电子新材料股份有限公司 2020-12-29 CN claimed
CN-108484843-A A kind of preparation method of makrolon material shell core toughener 焦桂钰 2018-09-04 CN claimed
US-5442086-A Ultraviolet light-absorbing compounds and sunscreen formulations and polymeric materials containing such compounds or residues thereof EASTMAN CHEMICAL COMPANY (US) 1995-08-15 US claimed
US-5374419-A For solutions or suspensions that absorb both ultraviolet-A and-B wavelengths EASTMAN CHEMICAL COMPANY (US) 1994-12-20 US claimed
US-5324616-A Encapsulated toner compositions and processes thereof XEROX CORPORATION (US) 1994-06-28 US claimed
US-5302740-A Ultraviolet light-absorbing compounds and sunscreen formulations and polymeric materials containing such compounds or residues thereof EASTMAN KODAK COMPANY (US) 1994-04-12 US claimed
EP-0413648-B1 Ultraviolet light-absorbing compounds and sunscreen formulations and polymeric materials containing such compounds or residues thereof EASTMAN KODAK CO (US) 1994-02-16 EP claimed
EP-0471783-A1 POLYMETHINE COMPOUNDS, AND POLYMER COMPOSITIONS CONTAINING THEM EASTMAN KODAK COMPANY (US) 1992-02-26 EP claimed
US-5045428-A Encapsulated toner compositions and processes thereof XEROX CORPORATION (US) 1991-09-03 US claimed
US-4994512-A Photostabilizers for vecerage and food containers of polyesters or polycarbonate; ultraviolet radiation resistance EASTMAN KODAK COMPANY (US) 1991-02-19 US claimed
WO-1990013597-A1 POLYMETHINE COMPOUNDS, AND POLYMER COMPOSITIONS CONTAINING THEM EASTMAN KODAK COMPANY (US) 1990-11-15 WO claimed
US-4387115-A COPPER DIHYDROXYBENZENE REDUCING AGENT, COPPER COMPOUND MITSUI TOATSU CHEMICALS, INC. (JP) 1983-06-07 US claimed
JP-59025181-A None JP disclosed
US-12570858-B2 Curable composition, cured product, cured film, display panel, and method for producing cured film TOKYO OHKA KOGYO CO., LTD. (JP) 2026-03-10 US disclosed
EP-4692256-A1 INK COMPOSITION, INK SET, INK PACK, AND INKJET RECORDING METHOD Maxell, Ltd. (JP) 2026-02-11 EP disclosed
JP-S5925181-A AIR ELECTRODE PENTEL KK 1984-02-09 JP disclosed
US-4387115-A COPPER DIHYDROXYBENZENE REDUCING AGENT, COPPER COMPOUND MITSUI TOATSU CHEMICALS, INC. (JP) 1983-06-07 US disclosed
US-4196175-A ONTO A MACRORETICULAR ORGANIC COMPOUND CONTAINING CARBONYL FUNCTIONAL GROUPTS TO FORM ADDUCT CHEVRON RESEARCH COMPANY (US) 1980-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570858-B2 Curable composition, cured product, cured film, display panel, and method for producing cured film C5, CFL1, C9 CHRNB2 1627/4885CHRNA4 2136/4885ALDH1A1 1968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.